Український медичний часопис · Nov 3, 2026
Biological age trajectories and cardiovascular protection throughout life
By А.В. О
The article presents a scientific and analytical review of presentations by leading European experts at the 2026 Congress of the European Society of Cardiology (European Society of Cardiology — ESC) in Munich, Germany, devoted to a paradigm shift in prevention—from chronological age to biological age trajectories, frailty syndrome, and the lifetime burden of risk factors. Safe deprescribing of antihypertensive agents in older adults is analyzed based on data from the RETREAT-FRAIL study. The concept of lifelong control of low-density lipoprotein cholesterol levels is substantiated: from early childhood screening (the VRONI and RareScreen programs) to geriatric prevention. Particular attention is paid to anticoagulant protection in patients aged ≥85 years with atrial fibrillation based on data from national registries and the ELDERCARE-AF study, as well as to criteria for dose reduction of direct oral anticoagulants.